SERPINA1 and lung cancer: Higashiyama M et al, in a clinical follow-up study of the patients with lung cancer, particularly in stage I, showed that strongly α1-AT -positive cases have poor prognosis than weak-to-moderately α1-AT -positive or α1-AT -negative cases.